Postprandial hyperglycemia and cardiovascular events. Acarbose therapy in patients with coronary heart disease and impaired carbohydrate metabolism

The article is focused on postprandial hyperglycemia role in cardiovascular event (CVE) development. Modern views on postprandial hyperglycemia pathogenetic mechanisms, its effects on type 2 diabetes mellitus progression and CVE are presented. Postprandial hyperglycemia control with an alpha-glucosi...

Full description

Bibliographic Details
Main Authors: N. A. Logunova, M. G. Bubnova, N. V. Perova
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2008-10-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1262
Description
Summary:The article is focused on postprandial hyperglycemia role in cardiovascular event (CVE) development. Modern views on postprandial hyperglycemia pathogenetic mechanisms, its effects on type 2 diabetes mellitus progression and CVE are presented. Postprandial hyperglycemia control with an alpha-glucosidase inhibitor acarbose is discussed, and data are presented on acarbose influence on physical fitness and atherogenic metabolic factors in patients with coronary heart disease and impaired carbohydrate metabolism.
ISSN:1728-8800
2619-0125